Assessing Quality of Life Post-Breast Reconstruction Surgery: Findings from an Interim Analysis of the REKO 001 Three-Arm Clinical Trial with a Decade of Follow-Up - Summary - MDSpire
Conexiant’s news site is now MDSpire News. Learn more
Advertisement
Assessing Quality of Life Post-Breast Reconstruction Surgery: Findings from an Interim Analysis of the REKO 001 Three-Arm Clinical Trial with a Decade of Follow-Up
To evaluate health-related quality of life (HRQoL) specifically in breast cancer patients post-surgery undergoing different surgical procedures over a long-term follow-up.
Approach:
Key Findings:
Patients undergoing DIEP/FCI reconstruction reported improved quality of life at 5 months post-surgery despite higher complication rates (p-value needed).
Significant differences in age and previous surgeries were noted among the groups, with the mastectomy group being older (specific statistics needed).
A total of 204 questionnaires were returned at the 5-month follow-up (T2), with a loss of 30 patients from initial enrollment.
Interpretation:
The findings suggest that while DIEP/FCI reconstruction has a higher complication rate, it may lead to better HRQoL outcomes compared to mastectomy and implant-based reconstruction, influencing surgical decision-making.
Limitations:
The study is limited by its single-center design and potential biases in patient selection, which may affect the results.
A significant loss to follow-up may affect the generalizability of the results, necessitating caution in interpretation.
Conclusion:
The interim analysis indicates that autologous reconstruction can enhance quality of life shortly after surgery, providing valuable insights for surgical decision-making in breast cancer treatment and highlighting areas for future research.
Harold Burstein, MD, PhD, and Laura S. Dominici, MD, FACS, discuss highlights from the SENOMAC trial which sheds light on whether some patients with early breast cancer and limited lymph node involvement can safely avoid additional axillary surgery.